Research progress of targeted drugs in breast cancer treatment

Abstract

Abstract: Because of its specificity, significant effect, low side effect, molecular targeted therapy has been applied in the treatment of breast cancer. Recently, various molecular targeted drugs have been exploited including targeted HER family, VEGF, multi-targeted therapeutic drugs, and drugs combination.

Key words: breast cancer, molecular targeted therapy, HER family, VEGF

CLC Number:

R730

Cite this article

share this article

/ Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal11.magtechjournal.com/Jwk_jcyxylc/EN/

https://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2015/V35/I1/134

References

Related Articles 15

[1]	SU Lingfeng, WANG Huxia, WANG Yanfeng, SONG Zhangjun. Impact of chronic stress on the development of breast cancer [J]. Basic & Clinical Medicine, 2024, 44(9): 1303-1307.
[2]	XIA Yujia, YANG Zhenli, DAI Di, LIU Yuqin. Culture and characterization of breast cancer organoids [J]. Basic & Clinical Medicine, 2024, 44(9): 1223-1228.
[3]	WANG Luyi, XU Kaifeng. Factors associated with lymphangioleiomyomatosis progression and mortality [J]. Basic & Clinical Medicine, 2024, 44(7): 1044-1048.
[4]	CAO Qingwen, QI Lin, YU Bo, TIAN Chenchen, YUAN Haining, WANG Yue. Salidroside promotes proliferation and migration of human vascular endothelial cell line EA.hy926 [J]. Basic & Clinical Medicine, 2024, 44(7): 925-930.
[5]	LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua. lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines [J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.
[6]	NAN Lu, GUO Menjie, GAO Yanan, JIA Hongyan. Research progress on the mechanism of annexin A family members in breast cancer [J]. Basic & Clinical Medicine, 2024, 44(3): 393-397.
[7]	Yiheliman·MAIMAITI, CAO Yanzhen, WANG Cuicui, YUE Na, LIANG Liping. Correlation between PIK3CA mutation and clinicopathological features and prognosis of breast cancer [J]. Basic & Clinical Medicine, 2024, 44(3): 303-307.
[8]	LI Jiangli, SUN Jing, TANG Yijun, GUO Junlan, CHEN Bo, GUO Shengnan. Circ-DDX5 inhibits the proliferation and invasion of human breast cancer cell lines by targeting miR-3940 [J]. Basic & Clinical Medicine, 2024, 44(1): 1-7.
[9]	CHEN Ning, PENG Tianying, ZHANG Weimiao, GAO Yanuo, LI Xuan, YAN Caizhen, LI Junxia. Synergistic pro-apoptotic effect of triptolide combined with doxorubicin in human breast cancer cell line MCF-7 [J]. Basic & Clinical Medicine, 2023, 43(8): 1186-1192.
[10]	WANG Jihui, CAO Jilie, ZHANG Lijun, ZHANG Jun, LU Wenbao. TARBP2 promotes human breast cancer cell metastasis by degrading AKAP12 transcript [J]. Basic & Clinical Medicine, 2023, 43(8): 1259-1264.
[11]	TANG Yijun, WANG Wenlong, LI Jiangli, YANG Huan, SUN Jing. LncRNA RP11-686D22.10 is related with the survival of breast cancer patients, affects the proliferation, invasion of breast cancer cell lines [J]. Basic & Clinical Medicine, 2023, 43(7): 1023-1029.
[12]	ZHOU Yue, LIN Jingna. miR-199-3p inhibits diabetes retinopathy in rats by targeting at VegfA [J]. Basic & Clinical Medicine, 2023, 43(7): 1084-1089.
[13]	TAN Shufen, YANG Xielan, YANG Linlin, LI Shuqing. Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer [J]. Basic & Clinical Medicine, 2023, 43(12): 1861-1865.
[14]	YANG Liangquan, YU Miao, JIANG Qian, ZHANG Minghui, YANG Haisong. miR-504 regulates proteasome activator and inhibits the proliferation and migration of breast cancer cell line MCF-7 [J]. Basic & Clinical Medicine, 2023, 43(1): 95-101.
[15]	WANG Qun, LI Xin, MA Jun, LI Wanming. Imaging of breast cancer targeted by the nucleic acid aptamer W3-quantum dots [J]. Basic & Clinical Medicine, 2023, 43(1): 76-82.

Metrics

Viewed

Full text

Abstract

Comments

Abstract
References
Related Articles
Recommended Articles
Metrics
Comments

TOP